37.77
price up icon0.56%   0.21
pre-market  Pre-market:  37.86   0.09   +0.24%
loading
Harrow Inc stock is traded at $37.77, with a volume of 496.79K. It is up +0.56% in the last 24 hours and down -21.61% over the past month. Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
See More
Previous Close:
$37.56
Open:
$37.68
24h Volume:
496.79K
Relative Volume:
0.71
Market Cap:
$1.40B
Revenue:
$154.15M
Net Income/Loss:
$-33.58M
P/E Ratio:
-39.34
EPS:
-0.96
Net Cash Flow:
$-20.74M
1W Performance:
-1.95%
1M Performance:
-21.61%
6M Performance:
+52.48%
1Y Performance:
-16.18%
1-Day Range:
Value
$36.77
$38.53
1-Week Range:
Value
$36.20
$39.30
52-Week Range:
Value
$20.85
$54.19

Harrow Inc Stock (HROW) Company Profile

Name
Name
Harrow Inc
Name
Phone
615.733.4731
Name
Address
1A BURTON HILLS BLVD, NASHVILLE, CA
Name
Employee
382
Name
Twitter
Name
Next Earnings Date
2025-03-17
Name
Latest SEC Filings
Name
HROW's Discussions on Twitter

Compare HROW with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
HROW
Harrow Inc
37.77 1.39B 154.15M -33.58M -20.74M -0.96
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
144.09 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.44 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.27 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.48 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
445.43 19.53B 3.08B 1.24B 1.07B 25.61

Harrow Inc Stock (HROW) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-11-25 Initiated Cantor Fitzgerald Overweight
Jun-12-25 Initiated BTIG Research Buy
Jun-10-25 Initiated William Blair Outperform
Feb-06-25 Initiated H.C. Wainwright Buy
Dec-04-24 Reiterated B. Riley Securities Buy
Apr-11-24 Initiated Craig Hallum Buy
Sep-08-22 Resumed B. Riley Securities Buy
Oct-14-21 Resumed B. Riley Securities Buy
Sep-24-21 Initiated Aegis Capital Buy
Jul-02-21 Initiated Ladenburg Thalmann Buy
View All

Harrow Inc Stock (HROW) Latest News

pulisher
06:40 AM

Westside Investment Management Inc. Raises Stake in Harrow, Inc. $HROW - MarketBeat

06:40 AM
pulisher
01:59 AM

Key resistance and support levels for Harrow Inc.July 2025 Snapshot & Daily Risk Controlled Trade Plans - newser.com

01:59 AM
pulisher
Nov 02, 2025

Can Harrow Inc. stock sustain market leadershipTrade Signal Summary & Technical Pattern Alert System - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How Harrow Inc. stock reacts to global recession fearsRate Cut & Verified Momentum Watchlists - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What is the fair value of Harrow Inc. stock nowJuly 2025 Retail & Risk Adjusted Swing Trade Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Should you hold or exit Harrow Inc. nowJuly 2025 Big Picture & Weekly Market Pulse Updates - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What insider trading reveals about Harrow Inc. stockProfit Target & Step-by-Step Trade Execution Guides - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Harrow, Inc. (HROW) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Nov 01, 2025
pulisher
Nov 01, 2025

Best data tools to analyze Harrow Inc. stock2025 Investor Takeaways & Expert Approved Trade Ideas - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Custom watchlist performance reports with Harrow Inc.Weekly Earnings Recap & Community Verified Trade Signals - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Why Harrow Inc. stock is in analyst buy zone2025 Winners & Losers & Risk Managed Investment Strategies - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

What risks investors should watch in Harrow Inc. stockWeekly Trade Analysis & Reliable Entry Point Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Will Harrow Inc. stock pay special dividends2025 Bull vs Bear & AI Powered Market Trend Analysis - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Corrado Advisors LLC Purchases Shares of 7,366 Harrow, Inc. $HROW - MarketBeat

Oct 30, 2025
pulisher
Oct 29, 2025

Analyzing Harrow Inc. with risk reward ratio chartsPortfolio Profit Report & Trade Opportunity Analysis - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

D.A. Davidson & CO. Sells 13,255 Shares of Harrow, Inc. $HROW - MarketBeat

Oct 28, 2025
pulisher
Oct 27, 2025

Harrow, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Indicators - Markets Mojo

Oct 27, 2025
pulisher
Oct 27, 2025

Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025 - The Manila Times

Oct 27, 2025
pulisher
Oct 27, 2025

Harrow (NASDAQ: HROW) sets third-quarter results Nov 10; call and webcast Nov 11 - Stock Titan

Oct 27, 2025
pulisher
Oct 27, 2025

Kornitzer Capital Management Inc. KS Acquires New Position in Harrow, Inc. $HROW - MarketBeat

Oct 27, 2025

Harrow Inc Stock (HROW) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$45.46
price up icon 3.18%
$22.15
price down icon 1.86%
drug_manufacturers_specialty_generic RDY
$13.29
price down icon 1.19%
$10.36
price up icon 0.00%
$143.21
price up icon 3.75%
$445.43
price down icon 1.79%
Cap:     |  Volume (24h):